Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Imatinib
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01EX
- Strength
- 400 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 087793
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 87,982.91 to 92,329.27 (+4.9%) between 18 Aug 2025 and 17 Aug 2026 · 2 official price records · pack 30's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. IM 400 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/im-400-mg-087793-30s-werrick-pharmaceuticals/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 92,329.27 | 2026-08-17 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 87,982.91 | 2025-08-18 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 087793Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
